Skip to Main Content

Here you can browse the complete list of publications for NLST.

Publication Year

Results: 131 (Showing 21 to 40) — Export these results

Title PubMed Id Authors Journal Abbreviation Year Studies
Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules. 28439653 Chung K, Jacobs C, Scholten ET, Mets OM, Dekker I, Prokop M, van Ginneken B, Schaefer-Prokop CM Eur Radiol 2017 NLST
Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules? 28339311 Chung K, Jacobs C, Scholten ET, Goo JM, Prosch H, Sverzellati N, Ciompi F, Mets OM, Gerke PK, Prokop M, van Ginneken B, Schaefer-Prokop CM Radiology 2017 NLST
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. 27387658 Balekian AA, Tanner NT, Fisher JM, Silvestri GA, Gould MK Ann Am Thorac Soc 2016 NLST
Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration. 27330355 Evans WK, Flanagan WM, Miller AB, Goffin JR, Memon S, Fitzgerald N, Wolfson MC Curr Oncol 2016 NLST
The Potential Clinical, Resource Use, And Fiscal Impacts of Lung-Rads To Inform Lung Cancer Screening In Medicare J. Roth, S.D. Sullivan, S. Ramsey, B. Goulart Val Health 2016 NLST
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening. 27179989 Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK JAMA 2016 NLST
Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. 27009070 Patz EF, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR Lancet Oncol. 2016 NLST
Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network. 27664507 Petousis P, Han SX, Aberle D, Bui AA Artif Intell Med 2016 NLST
Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening Trial Barbara L. McComb, Reginald F. Munden, Fenghai Duan, Amanda A. Jain, Catherine Tuite, Caroline Chiles Clin Imaging 2016 NLST
Lung Cancer Deaths in the National Lung Screening Trial Attributed to Nonsolid Nodules. 27378239 Yip R, Yankelevitz DF, Hu M, Li K, Xu DM, Jirapatnakul A, Henschke CI Radiology 2016 NLST
Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial? 27006427 Marcus PM, Doria-Rose VP, Gareen IF, Brewer B, Clingan K, Keating K, Rosenbaum J, Rozjabek HM, Rathmell J, Sicks J, Miller AB Clin Trials 2016 NLST
Evaluating Long-Term Outcomes via Computed Tomography in Lung Cancer Screening Dongfeng Wu, Ruiqi Liu, Beth Levitt, Tom Riley, Kathy B. Baumgartner J Biom Biostat 2016 NLST
CANARY Risk Management of Adenocarcinoma: The Future of Imaging? Finbar Foley Srinivasan Rajagopalan Sushravya M. Raghunath Jennifer M. Boland Ronald A. Karwoski Fabien Maldonado Brian J. Bartholmai Tobias Peikert j.semtcsv 2016 NLST
Performance of Lung-RADS in the National Lung Screening Trial: A Retrospective Assessment. 25664444 Pinsky PF, Gierada DS, Black W, Munden R, Nath H, Aberle D, Kazerooni E Ann. Intern. Med. 2015 NLST
A Query Tool for Investigator Access to the Data and Images of the National Lung Screening Trial. 25739345 Commean PK, Rathmell JM, Clark KW, Maffitt DR, Prior FW J Digit Imaging 2015 NLST
Computed Tomography Screening for Lung Cancer in the National Lung Screening Trial: A Cost-effectiveness Analysis. 25635704 Black WC J Thorac Imaging 2015 NLST
The Relations between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Cancer Screening Trial: Implications for Public Health. 25746779 Clark MA, Gorelick JJ, Sicks JD, Park ER, Graham AL, Abrams DB, Gareen IF Nicotine Tob. Res. 2015 NLST
Lung Cancer Detectability by Test, Histology, Stage, and Gender: Estimates from the NLST and the PLCO Trials. 25312998 Ten Haaf K, van Rosmalen J, de Koning HJ Cancer Epidemiol. Biomarkers Prev. 2015 NLST, PLCO
A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor. 25863905 Wilson DO, Weissfeld J Lung Cancer 2015 NLST
Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening. 26372542 Howard DH, Richards TB, Bach PB, Kegler MC, Berg CJ Cancer 2015 NLST